# OnCo record biotroy-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/biotroy-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "biotroy-therapeutics" ;
  schema:name "Biotroy Therapeutics"@en ;
  schema:alternateName "BioTroy"@en, "Shanghai Biotroy Biotechnology"@en ;
  schema:description "Biotroy Therapeutics is a Shanghai company developing antibodies against newly discovered immune checkpoints, the brakes that tumours use to switch off the immune system. Its first antibody, BT02, is in early trials in melanoma, lung cancer and blood cancers."@en ;
  schema:url <https://onco.cc/companies/biotroy-therapeutics/>, <http://www.biotroy.cn/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <http://www.biotroy.cn/>, <https://clinicaltrials.gov/study/NCT07107178>, <https://clinicaltrials.gov/study/NCT07110363>, <https://clinicaltrials.gov/study/NCT07107204> ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> .
